Routes of
administration Oral Synonyms MK-1439 PubChem CID 58460047 | ATC code none CAS Number 1338225-97-0 Molar mass 425.75 g/mol | |
 | ||
Legal status US: Investigational New Drug | ||
Doravirine (MK-1439) is a non-nucleoside reverse transcriptase inhibitor under development by Merck & Co. for use in the treatment of HIV/AIDS. Doravirine demonstrated robust antiviral activity and good tolerability in a small clinical study of 7-day monotherapy reported at the 20th Conference on Retroviruses and Opportunistic Infections in March 2013. Doravirine appeared safe and generally well-tolerated with most adverse events being mild-to-moderate.
References
Doravirine Wikipedia(Text) CC BY-SA